FDA Inspection 1170087 — OU Health Reproductive Medicine Lab
The FDA completed an inspection of OU Health Reproductive Medicine Lab on April 18, 2022 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 18, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Oklahoma City, OK (United States)